Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.46 Up 0.00(0.77%) May 27, 4:00PM EDT
Prev Close:0.45
Open:0.46
Bid:0.33 x 1500
Ask:0.52 x 7000
1y Target Est:1.92
Beta:0.648243
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:0.45 - 0.46
52wk Range:0.25 - 2.46
Volume:272,391
Avg Vol (3m):1,008,960
Market Cap:129.70M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICUp 0.77%129.70M
BMYUp 0.82%119.04B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.25
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback